Levitaccord is one brand name for levetiracetam. According to the Australian Medicines Handbook (AMH), Levetiracetam is indicated for focal (partial) seizures, for primary generalized tonic-clonic seizures associated with idiopathic generalized epilepsy, and for myoclonic seizures associated with juvenile myoclonic epilepsy in people 12 years and older.
Levitaccord is an antiepileptic, or drug that prevents seizures. It is believed that Levitaccord works in cases of epilepsy by inhibiting nerve signals.
How do I take it?
Levitaccord comes in tablet form.
The AMH lists common side effects for Levitaccord including dizziness, drowsiness, headache, weakness, insomnia, anxiety, depression, moodiness, aggression, agitation, double vision, and loss of appetite.
Rare but serious side effects listed for Levitaccord include blood disorders, toxic epidermal necrolysis or Stevens-Johnson syndrome (potentially life-threatening disorders of skin and mucous membranes), and multi-organ hypersensitivity syndrome (a potentially life-threatening condition).
For more information about this treatment, visit:
Levetiracetam — NPS Medicinewise